KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nektar Therapeutics (NKTR) Income from Continuing Operations (2016 - 2025)

Nektar Therapeutics has reported Income from Continuing Operations over the past 16 years, most recently at 34733000.0 for Q4 2025.

  • Quarterly results put Income from Continuing Operations at 34733000.0 for Q4 2025, down 578.35% from a year ago — trailing twelve months through Dec 2025 was 155349000.0 (down 30.59% YoY), and the annual figure for FY2025 was 155349000.0, down 30.59%.
  • Income from Continuing Operations for Q4 2025 was 34733000.0 at Nektar Therapeutics, up from 34988000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for NKTR hit a ceiling of 232779000.0 in Q4 2023 and a floor of 159068000.0 in Q2 2022.
  • Median Income from Continuing Operations over the past 5 years was 51742500.0 (2023), compared with a mean of 58304850.0.
  • Biggest five-year swings in Income from Continuing Operations: soared 508.53% in 2023 and later plummeted 578.35% in 2025.
  • Nektar Therapeutics' Income from Continuing Operations stood at 146907000.0 in 2021, then soared by 61.21% to 56980000.0 in 2022, then soared by 508.53% to 232779000.0 in 2023, then tumbled by 96.88% to 7261000.0 in 2024, then plummeted by 578.35% to 34733000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 34733000.0 (Q4 2025), 34988000.0 (Q3 2025), and 39207000.0 (Q2 2025) per Business Quant data.